English
A A A
EN
Bereichsnavigation

Vorherige
Managers' Transactions & Directors' Dealings | 29.01.2013

DGAP-News: RHÖN-KLINIKUM AG: State of Hesse and RHÖN-KLINIKUM AG agree future concept for the University Hospital Giessen and Marburg (UKGM) (english)

DGAP-News: RHÖN-KLINIKUM AG: State of Hesse and RHÖN-KLINIKUM AG agree future concept for the University Hospital Giessen and Marburg (UKGM) (english)

RHÖN-KLINIKUM AG: State of Hesse and RHÖN-KLINIKUM AG agree future concept

for the University Hospital Giessen and Marburg (UKGM)



DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Agreement/Miscellaneous

RHÖN-KLINIKUM AG: State of Hesse and RHÖN-KLINIKUM AG agree future

concept for the University Hospital Giessen and Marburg (UKGM)



29.01.2013 / 12:28



---------------------------------------------------------------------



RHÖN-KLINIKUM AG



State of Hesse and RHÖN-KLINIKUM AG agree future concept for the University

Hospital Giessen and Marburg (UKGM)



- Safeguarding of jobs until 2014 through a moratorium



- Support for research and teaching



- Further investments in medical technology and buildings



- Increased co-determination and control rights



- Particle therapy center in Marburg scheduled to start no later than

December 31, 2013



- Economic restructuring of UKGM



Bad Neustadt a. d. Saale, January 29, 2013



The Hesse state government, RHÖN-KLINIKUM AG and the two universities in

Giessen and Marburg have reached a joint agreement on the future of the

University Hospital Giessen and Marburg (UKGM). The agreed objectives are

to further develop high-quality medical care in Central Hesse, ensure

first-class research and teaching, improve job security for the around

9,700 employees, and strengthen the cooperation between the state, the

universities, the UKGM and its operator, RHÖN-KLINIKUM AG.



Agreement was also reached on the start of the particle therapy centre in

Marburg's Lahnbergen hills no later than the end of 2013. It was further

established that work would begin on renovating existing buildings and the

construction of three new clinics. In return, UKGM is to receive investment

grants from Hesse as well as compensation of EUR3 million per year to

support research and teaching in two separate locations.



'We therefore believe that we have come close to achieving our primary

objective of equal treatment with comparable university hospitals in

Hesse,' said Dr. Dr. Martin Siebert, Chairman of the Board of Management at

RHÖN-KLINIKUM AG.



In February 2006, RHÖN-KLINIKUM AG assumed responsibility for high-quality

medical care and 9,700 jobs in the Central Hesse region with a high level

of commitment.



'Rhön stands for innovation, reliability and sustainable management. We

intend to continue on this path in future by supporting advanced

university-based medical science as well as research and teaching at state

and local community level,' said Dr. Dr. Martin Siebert. Since 2006, around

EUR550 million has been invested in the region to support high-quality

medicine and secure jobs.' In order to serve the best interests of

patients, we wish to and will only be able to continue on this path by

working together. I would therefore like to thank all participants for

their dedicated commitment, in particular the Prime Minister of Hesse, the

Minister of Science and the two university presidents,' continued Dr. Dr.

Siebert.



Martin Menger, Chairman of the Management Board at University Hospital

Giessen and Marburg, added: 'With the help of the McKinsey report we were

already able to identify a number of new approaches last fall that had

become necessary due to the significant deterioration in framework

conditions, such as the situation at base rates and price discounts on

additional service volumes. We can address some of these challenges

ourselves. Others require the support of the State of Hesse. On the basis

of our joint agreement, we are confident that UKGM will be able to develop

successfully in future from an economic, medical and health care

perspective.'



Details of the agreement:

- Particle therapy and the treatment of patients scheduled to start in

Marburg no later than December 31 of this year; in return the State of

Hesse will not pursue legal claims through court proceedings



- A moratorium on recruitment until the end of 2014. To this end

open-ended discussions on the results of the McKinsey report will be

held with works councils and social partners.



- The UKGM will take on 150 of the 367 so-called returnees as part of a

personnel sharing agreement. Around 100 will remain with the State of

Hesse. Early retirement options will be considered for others.



- Beginning in 2013, RHÖN-KLINIKUM AG will start construction work on

three new clinics in Giessen and Marburg and carry out essential

renovation measures at other sites.



- Increased co-determination and control rights of the State of Hesse are

to be realized through four additional members of the supervisory

board, a newly created advisory council and an ombudsman.



Contacts:



RHÖN-KLINIKUM AG

Corporate Communications

Schlossplatz 1

97616 Bad Neustadt a. d. Saale

Phone: +49 9771 65-1304

Fax: +49 9771 65-1820

Email: kommunikation@rhoen-klinikum-ag.com



RHÖN-KLINIKUM AG

Dr. Kai G. Klinger

Head of Investor Relations

Schlossplatz 1

D-97616 Bad Neustadt a. d. Saale

Phone: +49 9771 65-1318

Fax: +49 9771 99-1736

E-Mail: kai.klinger@rhoen-klinikum-ag.com





End of Corporate News



---------------------------------------------------------------------



29.01.2013 Dissemination of a Corporate News, transmitted by DGAP - a

company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.



DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de



---------------------------------------------------------------------





Language: English

Company: RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a.d.Saale

Germany

Phone: +49 (0)9771 - 65-0

Fax: +49 (0)9771 - 97 467

E-mail: rka@rhoen-klinikum-ag.com

Internet: www.rhoen-klinikum-ag.com

ISIN: DE0007042301

WKN: 704230

Indices: MDAX

Listed: Regulierter Markt in Frankfurt (Prime Standard), München;

Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart





End of News DGAP News-Service

---------------------------------------------------------------------

200054 29.01.2013









Weitere Informationen: www.dpa-AFX.de

Experten finden

Unsere Kliniken

Kontakt

Tel: +49 9771 65-0

Cookies ändern